Contents
Current Medicinal Chemistry, Volume 10 - Number 12
Iron Chelator Research: Past, Present, and Future
, 10(12): 983 - 995Tim F. Tam, Regis Leung-Toung, Wanren Li, Yingsheng Wang, Khashayar Karimian and Michael Spino
DOI: 10.2174/0929867033457593
An Overview of Iron Metabolism: Molecular and Cellular Criteria for the Selection of Iron Chelators
, 10(12): 997 - 1004Robert R. Crichton and Roberta J. Ward
DOI: 10.2174/0929867033457566
The HAG Mechanism: A Molecular Rationale For The Therapeutic Application Of Iron Chelators In Human Diseases Involving the 2-Oxoacid Utilizing Dioxygenases
, 10(12): 1005 - 1019Hartmut M. Hanauske-Abel and Anthony M. Popowicz
DOI: 10.2174/0929867033457601
The Role of Iron Chelation in Cancer Therapy
, 10(12): 1021 - 1034Joan L. Buss, Frank M. Torti and Suzy V. Torti
DOI: 10.2174/0929867033457638
Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators
, 10(12): 1035 - 1049D. B. Lovejoy and D. R. Richardson
DOI: 10.2174/0929867033457557
Emerging Understanding of the Advantage of Small Molecules such as Hydroxypyridinones in the Treatment of Iron Overload
, 10(12): 1051 - 1064Robert C. Hider and Zu D. Liu
DOI: 10.2174/0929867033457629
Development of Tridentate Iron Chelators: From Desferrithiocin to ICL670
, 10(12): 1065 - 1076Hanspeter Nick, Pierre Acklin, Rene Lattmann, Peter Buehlmayer, Suzanne Hauffe, Joachim Schupp and Daniele Alberti
DOI: 10.2174/0929867033457610
Hydroxyquinolines as Iron Chelators
, 10(12): 1077 - 1084J.- L. Pierre, P. Baret and G. Serratrice
DOI: 10.2174/0929867033457584
Webmaster Contact: info@benthamscience.net